P53/PUMA expression in human pulmonary fibroblasts mediates cell activation and migration in silicosis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Wang, Wei ^a,b,d   Liu, Haijun ^b,c   Dai, Xiaoniu ^b   Fang, Shencun ^d   Wang, Xingang ^b   Zhang, Yingming ^d   Yao, Honghong ^b   Zhang, Xilong ^a   Chao, Jie ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c CHINA PHARMACEUTICAL UNIVERSITY   (China)

^d NANJING CHEST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BBC3 PROTEIN, HUMAN; COLLAGEN; MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; SILICON DIOXIDE; SMALL INTERFERING RNA;

ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; SIGNAL TRANSDUCTION; SILICOSIS; X-RAY COMPUTED TOMOGRAPHY;

APOPTOSIS REGULATORY PROTEINS; CELL MOVEMENT; CELL SURVIVAL; COLLAGEN; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SILICON DIOXIDE; SILICOSIS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84947258545     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep16900     Document Type: Article

References (58)

1. Keogh, B. A. & Crystal, R. G. Alveolitis: the key to the interstitial lung disorders. Thorax 37, 1-10 (1982).
2. Ward, P. A. & Hunninghake, G. W. Lung inflammation and fibrosis. Am J Respir Crit Care Med 157, S123-129, doi: 10.1164/ajrccm.157.4.nhlbi-10 (1998).
3. Gottlieb, T. M. & Oren, M. p53 in growth control and neoplasia. Biochim Biophys Acta 1287, 77-102 (1996).
4. Giaccia, A. J. & Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev 12, 2973-2983 (1998).
5. Sherr, C. J. Tumor surveillance via the ARF-p53 pathway. Genes Dev 12, 2984-2991 (1998).
6. Ashcroft, M. & Vousden, K. H. Regulation of p53 stability. Oncogene 18, 7637-7643, doi: 10.1038/sj.onc.1203012 (1999).
7. Jimenez, G. S., Khan, S. H., Stommel, J. M. & Wahl, G. M. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses. Oncogene 18, 7656-7665, doi: 10.1038/sj.onc.1203013 (1999).
8. Roger, L., Gadea, G. & Roux, P. Control of cell migration: a tumour suppressor function for p53? Biol Cell 98, 141-152, doi: 10.1042/BC20050058 (2006).
9. Metcalfe, A. M., Dixon, R. M. & Radda, G. K. Wild-type but not mutant p53 activates the hepatocyte growth factor/scatter factor promoter. Nucleic Acids Res 25, 983-986, doi: gka176 (1997).
10. Zhao, R. et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14, 981-993 (2000).
11. Iotsova, V. & Stehelin, D. Down-regulation of fibronectin gene expression by the p53 tumor suppressor protein. Cell Growth Differ 7, 629-634 (1996).
12. Mukhopadhyay, D., Tsiokas, L. & Sukhatme, V. P. Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55, 6161-6165 (1995).
13. Sun, Y., Wenger, L., Rutter, J. L., Brinckerhoff, C. E. & Cheung, H. S. p53 down-regulates human matrix metalloproteinase-1 (Collagenase-1) gene expression. J Biol Chem 274, 11535-11540 (1999).
14. Zhang, F. et al. Proliferative and survival effects of PUMA promote angiogenesis. Cell Rep 2, 1272-1285, doi: 10.1016/j.celrep.2012.09.023 (2012).
15. Tang, X. et al. p53 is an important regulator of CCL2 gene expression. Curr Mol Med 12, 929-943 (2012).
16. Hacke, K. et al. Regulation of MCP-1 chemokine transcription by p53. Mol Cancer 9, 82, doi: 10.1186/1476-4598-9-82 (2010).
17. Shimizu, H. et al. Indoxyl sulfate upregulates renal expression of MCP-1 via production of ROS and activation of NF-kappaB, p53, ERK, and JNK in proximal tubular cells. Life Sci 90, 525-530, doi: 10.1016/j.lfs.2012.01.013 (2012).
18. Grinnell, F. & Petroll, W. M. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev Biol 26, 335-361 (2010).
19. Liu, X. et al. Role of human pulmonary fibroblast-derived MCP-1 in cell activation and migration in experimental silicosis. Toxicol Appl Pharmacol, doi: 10.1016/j.taap.2015.07.002 (2015).
20. Pampaloni, F., Reynaud, E. G. & Stelzer, E. H. The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8, 839-845, doi: 10.1038/nrm2236 (2007).
21. Grinnell, F. Fibroblast biology in three-dimensional collagen matrices. Trends Cell Biol 13, 264-269 (2003).
22. Rhee, S. & Grinnell, F. Fibroblast mechanics in 3D collagen matrices. Adv Drug Deliv Rev 59, 1299-1305, doi: 10.1016/j.addr.2007.08.006 (2007).
23. Rhee, S. Fibroblasts in three dimensional matrices: cell migration and matrix remodeling. Exp Mol Med 41, 858-865, doi: 10.3858/emm.2009.41.12.096 (2009).
24. Lee, D. J., Rosenfeldt, H. & Grinnell, F. Activation of ERK and p38 MAP kinases in human fibroblasts during collagen matrix contraction. Exp Cell Res 257, 190-197, doi: 10.1006/excr.2000.4866 (2000).
25. Moore, B. B. et al. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am J Physiol Lung Cell Mol Physiol 284, L342-349, doi: 10.1152/ajplung.00168.2002 (2003).
26. Rao, K. M., Porter, D. W., Meighan, T. & Castranova, V. The sources of inflammatory mediators in the lung after silica exposure. Environ Health Perspect 112, 1679-1686 (2004).
27. Huaux, F. New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7, 168-173, doi: 10.1097/ACI.0b013e32802bf8a5 (2007).
28. Hamilton, R. F., Jr., Thakur, S. A. & Holian, A. Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med 44, 1246-1258, doi: 10.1016/j.freeradbiomed.2007.12.027 (2008).
29. Thakur, S. A., Hamilton, R., Jr., Pikkarainen, T. & Holian, A. Differential binding of inorganic particles to MARCO. Toxicol Sci 107, 238-246, doi: 10.1093/toxsci/kfn210 (2009).
30. Leung, C. C., Yu, I. T. & Chen, W. Silicosis. Lancet 379, 2008-2018, doi: 10.1016/S0140-6736(12)60235-9 (2012).
31. Baggiolini, M. & Dahinden, C. A. CC chemokines in allergic inflammation. Immunol Today 15, 127-133, doi: 10.1016/0167-5699(94)90156-2 (1994).
32. Ransohoff, R. M., Glabinski, A. & Tani, M. Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev 7, 35-46 (1996).
33. Zickus, C. et al. Differential regulation of C-C chemokines during fibroblast-monocyte interactions: adhesion vs. inflammatory cytokine pathways. Mediators Inflamm 7, 269-274, doi: 10.1080/09629359890956 (1998).
34. Moore, B. B. et al. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J Immunol 167, 4368-4377 (2001).
35. Gharaee-Kermani, M., Denholm, E. M. & Phan, S. H. Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors. The Journal of biological chemistry 271, 17779-17784 (1996).
36. Rao, K. M. et al. Time course of gene expression of inflammatory mediators in rat lung after diesel exhaust particle exposure. Environ Health Perspect 113, 612-617 (2005).
37. Wong, L. S. & Martins-Green, M. Firsthand cigarette smoke alters fibroblast migration and survival: implications for impaired healing. Wound Repair Regen 12, 471-484, doi: 10.1111/j.1067-1927.2004.12403.x (2004).
38. Gadea, G., Lapasset, L., Gauthier-Rouviere, C. & Roux, P. Regulation of Cdc42-mediated morphological effects: a novel function for p53. Embo J 21, 2373-2382, doi: 10.1093/emboj/21.10.2373 (2002).
39. Guo, F. & Zheng, Y. Rho family GTPases cooperate with p53 deletion to promote primary mouse embryonic fibroblast cell invasion. Oncogene 23, 5577-5585, doi: 10.1038/sj.onc.1207752 (2004).
40. Villunger, A. et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302, 1036-1038, doi: 10.1126/science.1090072 (2003).
41. Chao, J. et al. Expression of green fluorescent protein in human foreskin fibroblasts for use in 2D and 3D culture models. Wound Repair Regen 22, 134-140, doi: 10.1111/wrr.12121 (2014).
42. Discher, D. E., Janmey, P. & Wang, Y. L. Tissue cells feel and respond to the stiffness of their substrate. Science 310, 1139-1143, doi: 10.1126/science.1116995 (2005).
43. Dokukina, I. V. & Gracheva, M. E. A model of fibroblast motility on substrates with different rigidities. Biophys J 98, 2794-2803, doi: 10.1016/j.bpj.2010.03.026 (2010).
44. Yu, J. & Zhang, L. PUMA, a potent killer with or without p53. Oncogene 27, Suppl 1, S71-83, doi: 10.1038/onc.2009.45 (2008).
45. Mandl, A., Huong Pham, L., Toth, K., Zambetti, G. & Erhardt, P. Puma deletion delays cardiac dysfunction in murine heart failure models through attenuation of apoptosis. Circulation 124, 31-39, doi: 10.1161/CIRCULATIONAHA.110.988303 (2011).
46. Altin, S. E. & Schulze, P. C. p53-upregulated modulator of apoptosis (PUMA): a novel proapoptotic molecule in the failing heart. Circulation 124, 7-8, doi: 10.1161/CIRCULATIONAHA.111.036178 (2011).
47. Bordin, S., Page, R. C. & Narayanan, A. S. Heterogeneity of normal human diploid fibroblasts: isolation and characterization of one phenotype. Science 223, 171-173 (1984).
48. Phipps, R. P. et al. Characterization of two major populations of lung fibroblasts: distinguishing morphology and discordant display of Thy 1 and class II MHC. Am J Respir Cell Mol Biol 1, 65-74, doi: 10.1165/ajrcmb/1.1.65 (1989).
49. Rodemann, H. P., Muller, G. A., Knecht, A., Norman, J. T. & Fine, L. G. Fibroblasts of rabbit kidney in culture. I. Characterization and identification of cell-specific markers. Am J Physiol 261, F283-291 (1991).
50. Smith, T. J. et al. Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts. J Clin Endocrinol Metab 80, 2620-2625, doi: 10.1210/jcem.80.9.7673404 (1995).
51. Das, M., Dempsey, E. C., Reeves, J. T. & Stenmark, K. R. Selective expansion of fibroblast subpopulations from pulmonary artery adventitia in response to hypoxia. Am J Physiol Lung Cell Mol Physiol 282, L976-986, doi: 10.1152/ajplung.00382.2001 (2002).
52. Katoh, S. et al. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia. J Allergy Clin Immunol 106, 730-736, doi: 10.1067/mai.2000.109827 (2000).
53. Chao, J., Wood, J. G., Blanco, V. G. & Gonzalez, N. C. The systemic inflammation of alveolar hypoxia is initiated by alveolar macrophage-borne mediator(s). Am J Respir Cell Mol Biol 41, 573-582, doi: 10.1165/rcmb.2008-0417OC (2009).
54. Carlson, M. A., Longaker, M. T. & Thompson, J. S. Modulation of FAK, Akt, and p53 by stress release of the fibroblast-populated collagen matrix. J Surg Res 120, 171-177, doi: 10.1016/j.jss.2003.12.002 (2004).
55. Bell, E., Ivarsson, B. & Merrill, C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76, 1274-1278 (1979).
56. Grinnell, F., Zhu, M., Carlson, M. A. & Abrams, J. M. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 248, 608-619, doi: S0014-4827(99)94440-3 (1999).
57. Grinnell, F., Rocha, L. B., Iucu, C., Rhee, S. & Jiang, H. Nested collagen matrices: a new model to study migration of human fibroblast populations in three dimensions. Exp Cell Res 312, 86-94, doi: 10.1016/j.yexcr.2005.10.001 (2006).
58. Carlson, M. A., Prall, A. K. & Gums, J. J. RNA interference in human foreskin fibroblasts within the three-dimensional collagen matrix. Mol Cell Biochem 306, 123-132, doi: 10.1007/s11010-007-9561-z (2007).